Zoledronic acid is effective in preventing and delaying skeletal events in patients with bone metastases secondary to genitourinary cancers

Fred Saad, Allan Lipton

Research output: Contribution to journalShort surveypeer-review

49 Scopus citations

Fingerprint Dive into the research topics of 'Zoledronic acid is effective in preventing and delaying skeletal events in patients with bone metastases secondary to genitourinary cancers'. Together they form a unique fingerprint.

Medicine & Life Sciences